Global autoimmune disease diagnostics market size was valued at USD4 billion in 2019 and projected to grow at a formidable CAGR during the forecast period. The key factor driving the growth of autoimmune disease diagnostics market is surging investment in healthcare sector. Additionally, growing cases of autoimmune diseases is further anticipated to bode well for the growth of autoimmune disease diagnostics market across the globe in the coming years. Moreover, increasing government support in terms of providing funds is projected to bolster the market growth through 2025. Moreover, growing implementation of lab automation technologies in developing nations such as U.S. and Europe are further aiding the market growth.

The global autoimmune disease diagnostics market is segmented based on type, sex, age, factors, diagnosis, types of treatment, product, end-user, region and company. Based on product, the market can be segmented into kits and assays, reagents and instruments. Out of which, the kits and assays segment dominated the market in terms of largest market size until 2019 and is further anticipated to maintain its leading position during the forecast period as well. This growth can be accredited to increasing adoption of kits and assays in hospitals and clinical laboratories. Moreover, increasing prevalence of autoimmune diseases coupled with growing requirement for fast results, is expected to boost the growth of the segment in the upcoming years.

Major players operating in the autoimmune disease diagnostics market include Siemens, Abbott, Bio-Rad Laboratories, Pfizer, Johnson and Johnson, Grifols, Trinity Biotech, Thermo Fisher Scientific, Inova Diagnostics, Hycor Biomedical, Euroimmun, Protagen, Roche, Quest Diagnostics, Hemagen Diagnostics, Aesku Diagnostics, Sanofi, Sun Pharmaceutical Industries Ltd., Eli Lilly, Bayer, etc. The companies operating in autoimmune disease diagnostics market across the globe are focussing more towards the expanding their share in the market. For instance, these key players are making organic strategies such as mergers and acquisitions, among others in order to survive the highly competitive industry. 

Years considered for this report:

Historical Years: 2015-2018                                                                         

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyse and forecast the market size of global autoimmune disease diagnostics market.
  • To classify and forecast global autoimmune disease diagnostics market based on type, sex, age, factors, diagnosis, types of treatment, product, end-user, company and regional distribution.
  • To identify drivers and challenges for global autoimmune disease diagnostics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global autoimmune disease diagnostics market.
  • To conduct pricing analysis for global autoimmune disease diagnostics market.
  • To identify and analyse the profile of leading players operating in global autoimmune disease diagnostics market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the new products, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global autoimmune disease diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.


Key Target Audience:

  • Autoimmune disease diagnostics companies and other stakeholders.
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to autoimmune disease diagnostics
  • Market research and consulting firms  

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global autoimmune disease diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Type:
    • Systemic
    • Organ-specific
  • Market, By Sex:
    • Male
    • Female
  • Market, By Age:
    • 0-15
    • 15-44
    • 44+
  • Market, By Factors:
    • Diet
    • Genetics
    • Environmental Agents
  • Market, By Diagnosis:
    • Antinuclear Antibody Test
    • Autoantibody Test
    • CBC
    • Comprehensive Metabolic Panel
    • C-reactive Protein
    • Erythrocyte Sedimentation Rate
    • Urinalysis
    • Imaging Test
    • Biopsy
  • Market, By Types of Treatment:
    • Nonsteroidal Anti-Inflammatory Drugs
    • Immune-Suppressing Drugs
    • Hormone Replacement Therapy
    • Physical Therapy
    • Blood Transfusion
    • Plasma Exchange
    • Others
  • Market, By Product:
    • Kits and Assays
    • Reagents
    • Instruments
  • Market, By End-User:
    • Hospital
    • Clinics
    • Diagnostic Laboratories
    • Others
  • Market, By Region:
    • North America
      • United States
      • Mexico
      • Canada
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • India 
      • Japan
      • South Korea
      • Australia
      • Singapore
    • Middle East and Africa
      • South Africa
      • Saudi Arabia
      • UAE
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global autoimmune disease diagnostics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Global Autoimmune Disease Diagnostics Market Outlook

4.1.  Market Size & Forecast

4.1.1.     By Value & Volume

4.2.  Market Share & Forecast

4.2.1.     By Type (Systemic, Organ-specific (Localized))

4.2.2.     By Sex (Male, Female)

4.2.3.     By Age (0-15, 15-44, 44+)

4.2.4.     By Factors (Diet, Genetics, Environmental agents)

4.2.5.     By Diagnosis (Antinuclear antibody test (ANR), Autoantibody test, CBC (Complete Blood Count), Comprehensive Metabolic Panel, C-reactive protein (CRP), Erythrocyte sedimentation rate (ESR), Urinalysis, Imaging test, Biopsy)

4.2.6.     By Types of Treatment (Nonsteroidal anti-inflammatory drugs (NSAIDs), Immune-suppressing drugs, Hormone replacement therapy, Physical therapy, Blood transfusion, Plasma Exchange, Others)

4.2.7.     By Product (Kits and assays, Reagents, Instruments)

4.2.8.     By End-User (Hospital, Clinics, Diagnostic laboratories, Others)

4.2.9.     By Company (2019)

4.2.10.  By Region

4.3.  Market Attractiveness Index

5.    Asia-Pacific Autoimmune Disease Diagnostics Market Outlook

5.1.  Market Size & Forecast          

5.1.1.     By Value & Volume

5.2.  Market Share & Forecast

5.2.1.     By Type

5.2.2.     By Sex

5.2.3.     By Age

5.2.4.     By Factors

5.2.5.     By Diagnosis

5.2.6.     By Types of Treatment

5.2.7.     By Product

5.2.8.     By End-User

5.2.9.     By Country

5.3.  Market Attractiveness Index

5.4.  Asia-Pacific: Country Analysis

5.4.1.     China Autoimmune Disease Diagnostics Market Outlook

5.4.1.1.         Market Size & Forecast

5.4.1.1.1.             By Value

5.4.1.2.         Market Share & Forecast

5.4.1.2.1.             By Type

5.4.1.2.2.             By Sex

5.4.1.2.3.             By Age

5.4.1.2.4.             By Factors

5.4.1.2.5.             By Diagnosis

5.4.1.2.6.